# Clonidine for Neonatal Abstinence Syndrome Study

> **NCT01175668** · NA · TERMINATED · sponsor: **Baystate Medical Center** · enrollment: 68 (actual)

## Conditions studied

- Neonatal Abstinence Syndrome

## Interventions

- **DRUG:** Clonidine
- **DRUG:** Phenobarbital

## Key facts

- **NCT ID:** NCT01175668
- **Lead sponsor:** Baystate Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2012-08
- **Final completion:** 2012-10
- **Target enrollment:** 68 (ACTUAL)
- **Why stopped:** Based on the planned interim analysis results at 50% recruitment, after IRB reviewed the results, further enrollment was stopped.
- **Last updated:** 2014-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01175668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01175668, "Clonidine for Neonatal Abstinence Syndrome Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01175668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*